# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Microbot Medical Inc. (NASDAQ:MBOT), developer and distributer of the innovative LIBERTY® Endovascular Robotic System, today an...
HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 pr...
The Experienced MedTech Logistics Provider Will Help Ensure Effective and Efficient Inventory Management and Customer Support T...
Commercial Focus Remains on U.S. Market as it Continues to Explore Certain Global Markets that Accept FDA Cleared Devices Prote...
Microbot Medical Inc. (NASDAQ:MBOT) ("Microbot" or the "Company"), today announced the entry into definitive ag...
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Microbot Medical (NASDAQ:MBOT) with a Buy and raises the price ...
Accelerated Launch Readiness Plans Position Company for Commercialization during Q4 2025The Company's Initial Addressable M...